Skip to main navigation Skip to search Skip to main content

Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: Implications for Parkinson's disease

  • Vasogen Ireland Ltd.
  • Vasogen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: Implications for Parkinson's disease'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience